Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast‐enhanced US
Year: 2013
Type: article
Source: Liver International
DOI: 10.1111/liv.12098
Institutions: Tokyo Medical University, Toshiba (Japan)
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2000774941
